GGHC
TTOO

Gilder Gagnon Howe & Co’s T2 Biosystems, Inc TTOO Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-82
Closed -$3.25M – 292
2016
Q2 		$3.25M Sell
82
-6
-7% -$271K 0.06% 141
2016
Q1 		$4.35M Sell
88
-7
-7% -$309K 0.09% 121
2015
Q4 		$5.19M Sell
95
-142
-60% -$7.66M 0.08% 119
2015
Q3 		$10.4M Sell
237
-26
-10% -$1.73M 0.16% 98
2015
Q2 		$21.4M Sell
263
-3
-1% -$260K 0.28% 71
2015
Q1 		$20.7M Sell
266
-17
-6% -$1.58M 0.29% 69
2014
Q4 		$27.2M Buy
283
+32
+13% +$2.64M 0.4% 62
2014
Q3 		$22.7M Buy
+251
New +$23.4M 0.33% 68

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gilder Gagnon Howe & Co's TTOO Position: Q3 2016 in Review

Gilder Gagnon Howe & Co sold out of T2 Biosystems, Inc (TTOO) in Q3 2016, closing a stake of 82 shares — an estimated $3.25M sold.

Gilder Gagnon Howe & Co first reported a position in TTOO in Q3 2014 and held it in 8 quarters. The position peaked at $27.2M in Q4 2014. 41 funds tracked by Wall St. Rank hold TTOO as of Q3 2016.

  • Gilder Gagnon Howe & Co reported no remaining T2 Biosystems, Inc position as of Q3 2016 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 82 T2 Biosystems, Inc shares in Q3 2016, an estimated $3.25M.
  • Gilder Gagnon Howe & Co first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 8 quarters.
  • Gilder Gagnon Howe & Co's T2 Biosystems, Inc position peaked at $27.2M in Q4 2014.
  • 41 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2016.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2016, filed 1 Nov 2016.